Eledon Pharmaceuticals
ELDN
ELDN
20 hedge funds and large institutions have $5.93M invested in Eledon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BI
BVF Inc
San Francisco,
California
|
+$837K |
2 |
O
OrbiMed
New York
|
+$653K |
3 |
6CM
683 Capital Management
New York
|
+$326K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$230K |
5 |
Renaissance Technologies
New York
|
+$210K |